Menu

Search

Felix Dube

Felix Dube

Senior Lecturer in the Department of Public Law, Faculty of Law, University of Pretoria, University of Pretoria
Dube Felix Dube is a Senior Lecturer in the Department of Public Law, Faculty of Law, University of Pretoria, where he teaches environmental law and administrative law. His research interests lie in administrative law, human rights and environmental law. He is also an assistant editor for the Journal of Law, Society and Development.

1 

Economy

Malaysia Weighs Growth Forecast Cut as U.S. Tariff Deadline Looms

Malaysia is likely to lower its 2025 GDP growth forecast of 4.5% to 5.5% due to rising trade tensions and looming U.S. tariffs, according to Bank Negara Malaysia Governor Abdul Rasheed Ghaffour. Speaking at an IMF event in...

Asian Stocks Edge Higher as Japan Gains, Korea Lags on Weak GDP

Asian stocks saw modest gains on Thursday, with Japan leading the region on renewed hopes of U.S. trade dialogue. Investors remained cautious, reassessing optimism over a potential de-escalation in the U.S.-China trade war...

U.S. Stock Futures Edge Higher on Trade Hopes, Alphabet Earnings in Focus

U.S. stock index futures inched higher Wednesday evening as optimism over easing U.S.-China trade tensions lifted sentiment. Investor focus also shifted toward key tech earnings, with Alphabet (NASDAQ: GOOGL) set to report...

U.S. Signals Possible Tariff Rollback Amid China Trade War Uncertainty

U.S. Treasury Secretary Scott Bessent signaled a potential shift in trade policy on Wednesday, calling the current tariff levels with China unsustainable. His comments come as markets react positively to hints that...

Oil Prices Edge Higher Amid OPEC+ Talks and Tariff Uncertainty

Oil prices saw a slight uptick early Thursday following a nearly 2% drop in the previous session, as markets react to potential OPEC+ output hikes, U.S.-China tariff discussions, and renewed U.S.-Iran nuclear negotiations....

Politics

Senator Dick Durbin to Retire, Opening Key Illinois Senate Race in 2026

U.S. Senator Dick Durbin (D-IL), the second-ranking Democrat in the Senate, announced he will not seek reelection in 2026, ending a 30-year tenure. His departure sets up a competitive Democratic primary in Illinois, a...

U.S. Demands Iran Halt Uranium Enrichment Ahead of Nuclear Talks

Ahead of a fresh round of nuclear talks, U.S. Secretary of State Marco Rubio reiterated that Iran must completely stop enriching uranium under any agreement with Washington, stressing that Tehran should import enriched...

U.S. Urges Swift Economic Pact with Ukraine Amid Tensions Over Peace Deal

U.S. Treasury Secretary Scott Bessent met with Ukrainian Prime Minister Denys Shmyhal and Finance Minister Sergii Marchenko on Wednesday, pushing for the swift finalization of a long-anticipated economic partnership. The...

Japan Urges U.S. to Ease Auto and Steel Tariffs Amid Tense Trade Talks

Japan has called on the United States to reconsider its tariffs on automobiles and steel during recent trade negotiations, but U.S. officials have refused to grant special treatment, according to a report by Japanese...

HHS Secretary Robert F. Kennedy Jr. to Testify Before Senate HELP Committee in May

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Health, Education, Labor, and Pensions (HELP) Committee in mid-May, Axios reported, citing an HHS spokesperson. His...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Nintendo Switch 2 Sees Surging Demand with 2.2 Million Lottery Applications in Japan

Nintendo has revealed that over 2.2 million people have entered a lottery for the new Switch 2 console in Japan, signaling overwhelming demand ahead of its June 5 launch. The company admitted it cannot fulfill all orders...

TSMC to Launch Advanced 1.4nm Chips by 2028 to Power AI Growth

Taiwan Semiconductor Manufacturing Company (TSMC), the worlds leading contract chipmaker and a key supplier to Nvidia (NASDAQ:NVDA), announced plans to begin mass production of its next-generation 1.4 nanometer (nm) chip...

SK Hynix Q1 Profit Soars on AI Chip Boom and Tariff Stockpiling

SK Hynix (KRX:000660) more than doubled its quarterly operating profit as demand for AI chips surged and clients stockpiled inventory ahead of potential U.S. tariffs. The worlds second-largest memory chipmaker posted an...

BMW to Integrate Chinese AI from DeepSeek in China-Made Vehicles

German automotive giant BMW (ETR:BMWG) announced it will begin integrating artificial intelligence (AI) developed by Chinese startup DeepSeek into its upcoming vehicle models in China starting later this year. The...

Tesla’s Optimus Robot Faces Delays Amid China’s Rare Earth Export Curbs

Tesla CEO Elon Musk revealed that production of the companys Optimus humanoid robot has been delayed due to Chinas new export restrictions on rare earth magnetscritical components in robotics and electric vehicles....
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.